976TiP SPEARHEAD-2 trial design: A phase II pilot trial of ADP-A2M4 in combination with pembrolizumab in patients with recurrent or metastatic head and neck cancer.

Autor:	Cohen, E.E.1 (AUTHOR), Dunn, L.2 (AUTHOR), Neupane, P.3 (AUTHOR), Gibson, M.4 (AUTHOR), Leidner, R.5 (AUTHOR), Savvides, P.6 (AUTHOR), Hyland, N.7 (AUTHOR), Trivedi, T.8 (AUTHOR), Dudley, M.9 (AUTHOR), Biswas, S.10 (AUTHOR), Williams, D.11 (AUTHOR), Norry, E.12 (AUTHOR)
Zdroj:	Annals of Oncology. 2020 Supplement 4, Vol. 31, pS685-S685. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu